Notably, the Nanoparticle Vaccine, COVOVAX, will be manufactured by Pune-based firm Serum Institute of India. Anti-viral drug Molnupiravir will be manufactured by 13 companies and it will be prescribed for restricted use for emergency purposes, such as treating adult patients who have contracted COVID-19 or the ones with 'high risk of progression of the disease', as per the Health Minister.